Search This Blog

Wednesday, November 6, 2019

Sangamo Therapeutics EPS beats by $0.11, beats on revenue

Sangamo Therapeutics (NASDAQ:SGMO): Q3 GAAP EPS of -$0.24 beats by $0.11.
Revenue of $21.96M (-6.8% Y/Y) beats by $9.8M.
Shares +2%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)